HexaLevers for Healthtech

Healthcare procurement is not like other B2B sales

Selling technology into healthcare systems, payers, and life sciences organizations involves layers of complexity that generic revenue tools simply ignore. Clinical validation requirements. HIPAA compliance reviews. Budget committees that meet quarterly. IT security assessments. C-suite sponsors who delegate evaluation to directors who delegate to analysts.

A single healthtech deal might involve 10-15 stakeholders across clinical, IT, compliance, procurement, and finance departments. Tracking that in Salesforce opportunity fields is a losing game. HexaLevers models the full buying committee and maps engagement across every stakeholder group.

• Buying committee mapping: Identify and track every stakeholder by role, department, and influence level. Get alerts when key personas go silent.
• Compliance milestone tracking: Model HIPAA reviews, security assessments, and clinical validation as distinct deal stages with their own progression benchmarks
• Budget cycle awareness: Healthtech deals often align to fiscal year budget cycles. HexaLevers incorporates budget timing into forecast predictions so you stop being surprised by Q4 freezes.
• Multi-stakeholder deal scoring: Deal health is evaluated across all stakeholder groups, not just the primary champion. A deal with strong clinical engagement but no IT buy-in gets flagged before it stalls.

"Our average deal has 12 stakeholders across four departments and takes eight months. Before HexaLevers, we had no idea which stakeholder group was blocking progress until it was too late." — Amanda Chen, CRO, MedBridge Solutions

Forecasting deals that take two or three quarters

When your average sales cycle is 180-270 days, forecasting is not about calling the current quarter — it is about predicting the next two or three. HexaLevers's models handle multi-quarter deal cycles by tracking progression velocity at each stage and comparing it against historical close patterns for similar deal profiles.

Healthtech companies using HexaLevers report:

• 41% improvement in forecast accuracy for deals with five or more stakeholders
• 33% reduction in deals lost to "no decision" (through earlier identification of stalled evaluations)
• 52% less time spent assembling pipeline reports for board and investor meetings

Compliance you can rely on

HexaLevers is SOC 2 Type II certified, HIPAA-ready, and GDPR compliant. Data is encrypted at rest and in transit, and our platform supports BAA agreements for customers who require them. Role-based access controls ensure that deal data is only visible to authorized team members.